StockData
IDEAYA Biosciences, Inc. logo

IDEAYA Biosciences, Inc. (IDYA) stock

IDYANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 3, 2026Score 10/3012% below fair value
$25.56−0.61 (-2.33%)

Close on Nov 20, 2026Market cap $2.47BP/E –Yield –

IDEAYA Biosciences free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

IDEAYA Biosciences's free cash flow for the twelve months ending Jun 30, 2026 was -$113.87M. For fiscal 2025 it was -$73.47M. The highest annual figure on record is $54.97M in fiscal 2020.

Annual free cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$73.47M–
FY2024Dec 31, 2024-$251.44M–
FY2023Dec 31, 2023-$117.59M–
FY2022Dec 31, 2022-$90.62M–
FY2021Dec 31, 2021-$58.42M-206.3%
FY2020Dec 31, 2020$54.97M–
FY2019Dec 31, 2019-$40.67M–
FY2018Dec 31, 2018-$29.33M–
FY2017Dec 31, 2017-$13.98M–

Quarterly free cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$89.08M–
Q1 FY2026Mar 31, 2026-$76.14M–
Q4 FY2025Dec 31, 2025-$90.83M–
Q3 FY2025Sep 30, 2025$142.17M–
Q2 FY2025Jun 30, 2025-$63.14M–
Q1 FY2025Mar 31, 2025-$61.67M–
Q4 FY2024Dec 31, 2024-$122.76M–
Q3 FY2024Sep 30, 2024-$49.69M–
Q2 FY2024Jun 30, 2024-$33.86M–
Q1 FY2024Mar 31, 2024-$45.14M–
Q4 FY2023Dec 31, 2023-$24.59M–
Q3 FY2023Sep 30, 2023-$30.78M–
Q2 FY2023Jun 30, 2023-$34.34M–
Q1 FY2023Mar 31, 2023-$27.89M–
Q4 FY2022Dec 31, 2022-$23.37M–
Q3 FY2022Sep 30, 2022-$25.27M–
Q2 FY2022Jun 30, 2022-$21.93M–
Q1 FY2022Mar 31, 2022-$20.05M–
Q4 FY2021Dec 31, 2021-$17.26M–
Q3 FY2021Sep 30, 2021-$12.93M-114.4%
Q2 FY2021Jun 30, 2021-$13.51M–
Q1 FY2021Mar 31, 2021-$14.73M–
Q4 FY2020Dec 31, 2020-$11.78M–
Q3 FY2020Sep 30, 2020$89.97M–
Q4 FY2019Dec 31, 2019-$8.92M–
Q3 FY2019Sep 30, 2019-$10.63M–
Q2 FY2019Jun 30, 2019-$10.72M–
Q1 FY2019Mar 31, 2019-$10.39M–
Q4 FY2018Dec 31, 2018-$7.79M–
Q3 FY2018Sep 30, 2018-$9.69M–

More IDEAYA Biosciences figures

See a number that looks wrong?